| Gheuens Sarah | Chief Medical Officer | 30,000Common stock | $900.6K | Sell | |
|---|
| Backstrom Jay T. | Director | 1,447Restricted stock units | $54.4K | Exercise / conversion | |
|---|
| Backstrom Jay T. | Director | 1,447Common stock | $54.4K | Grant / award | |
|---|
| Gheuens Sarah | Chief Medical Officer | 4,007Common stock | $151.9K | Sell | |
|---|
| Gheuens Sarah | Chief Medical Officer | 8,375Common stock | $317.4K | Exercise / conversion | |
|---|
| Backstrom Jay T. | Director | 14,950Stock options (right to buy) | $510.7K | Grant / award | |
|---|
| Backstrom Jay T. | Director | 2,927Restricted stock units | $100K | Grant / award | |
|---|
| Milanova Tsveta | Chief Commercial Officer | 3,000Restricted stock units | $102.5K | Grant / award | |
|---|
| Milanova Tsveta | Chief Commercial Officer | 3,000Performance share units | $102.5K | Exercise / conversion | |
|---|
| Jones Cecilia | Chief Financial Officer | 3,000Restricted stock units | $102.5K | Grant / award | |
|---|